Evotec is a drug discovery alliance and development partnership company focused on progressing innovative product approaches with leading pharma, biotechs, academics, patient advocacy groups and venture capitalists. Operating worldwide with more than 3,500 employees, provides the highest quality stand-alone and integrated drug discovery and development solutions from target to clinic, including INDiGO-Select and INDiGO, designed to de-risk and accelerate your IND-enabling programs.